Advertisement

Journal of Autism and Developmental Disorders

, Volume 49, Issue 1, pp 383–384 | Cite as

Correction to: Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children

  • Eric RubensteinEmail author
  • Jessica C. Young
  • Lisa A. Croen
  • Carolyn DiGuiseppi
  • Nicole F. Dowling
  • Li-Ching Lee
  • Laura Schieve
  • Lisa D. Wiggins
  • Julie Daniels
Correction

Correction to: Journal of Autism and Developmental Disorders  https://doi.org/10.1007/s10803-018-3721-8

The original version of this article unfortunately contained a mistake in Table 2. The “Time of use” should be the column header with the corresponding row with “N = 126” belonging to the “Peri-pregnancy” row. The "Preconception" row should be the row with “N = 17”, “Trimester 1” should be the “N = 29” row, “Trimester 2” should be the “N = 25” row, and “Trimester 3” should be the “N = 47” row.

The corrected Table 2 is given below.

Table 2

Unadjusted and adjusted odds ratios and 95% confidence intervals for the association between maternal opioid prescriptions in the peri-pregnancy period and child neurodevelopmental outcomes in children born from 2003 to 2012 enrolled in the Study to Explore Early Development

Time of use

Unadjusted

ASD

N = 1369

DD-only

N = 938

ASD/DD with autism featuresa

N = 1845

N

ORb

95% CI

N

OR

95% CI

N

OR

95% CI

Peri-pregnancyc

126

1.56

1.19, 2.06

66

1.17

0.84, 1.62

174

1.61

1.24, 2.08

Preconceptiond

17

2.82

1.27, 6.82

8

1.92

0.70, 5.34

23

2.83

1.21, 6.62

Trimester 1

29

1.99

1.09, 3.63

12

1.19

0.57, 2.50

36

1.83

1.02, 3.26

Trimester 2

25

1.52

0.84, 2.78

21

1.88

1.00, 3.52

38

1.72

0.99, 3.00

Trimester 3

47

1.16

0.77, 1.75

24

0.85

0.52, 1.41

63

1.15

0.78, 1.69

Time of use

Adjustede

ASD

N = 1359

DD-Only

N = 927

ASD/DD with autism features

N = 1834

N

aOR

95% CI

N

aOR

95% CI

N

aOR

95% CI

Peri-pregnancy

126

1.26

0.94, 1.68

66

1.06

0.76, 1.49

174

1.30

0.99, 1.71

Preconception

17

2.43

0.99, 6.02

8

1.94

0.68, 5.52

23

2.64

1.10, 6.31

Trimester 1

29

1.58

0.85, 2.94

12

1.06

0.50, 2.28

36

1.48

0.81, 2.69

Trimester 2

25

1.13

0.61, 2.12

21

1.64

0.87, 3.12

38

1.24

0.69, 2.22

Trimester 3

47

1.02

0.66, 1.57

24

0.85

0.52, 1.41

63

0.96

0.64, 1.45

ASD Autism spectrum disorder, DD-only developmental delay/disorder without features of ASD, OR odds ratio, aOR adjusted odds ratio, CI confidence interval

aASD/DD with autism features group includes children with autism spectrum disorder or non-ASD developmental delay/disorders with autism features

bExposure for case groups were compared to exposure for population controls at each time of use

c3 months preconception to 1 day prior to childbirth

d3 months preconception to conception

eAdjusted for maternal education, race/ethnicity, smoking during pregnancy, psychiatric condition prior to childbirth, and SEED study period (2003–2006 or 2007–2012). Ns are smaller due to missing covariate data

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Waisman CenterUniversity of Wisconsin-MadisonMadisonUSA
  2. 2.Department of Epidemiology, Gillings School of Global Public HealthUniversity of North Carolina Chapel HillChapel HillUSA
  3. 3.Kaiser Permanente Division of ResearchOaklandUSA
  4. 4.Department of Epidemiology, Colorado School of Public HealthUniversity of Colorado Anschutz Medical Campus School of Public HealthAuroraUSA
  5. 5.National Center on Birth Defects and Developmental DisabilitiesCenters for Disease Control and PreventionAtlantaUSA
  6. 6.Department of EpidemiologyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations